Statistics for Is short duration trastuzumab adequate adjuvant therapy for HER-2 overexpressing breast cancers?
Total visits
| views | |
|---|---|
| Is short duration trastuzumab adequate adjuvant therapy for HER-2 overexpressing breast cancers? | 11 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |